APTV vs PRAX · P/E 41, rev $19.71B vs rev $8.6M
Aptiv PLC (APTV) versus Praxis Precision Medicines Inc (PRAX) — a side-by-side from cached financials, not a winner call.
Aptiv PLC (APTV) is a auto parts company listed on US.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
Latest reported APTV revenue for 2024-12-31 was $19.71B. Net income was $275.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. APTV currently screens at market cap $14.52B and trailing P/E 40.8.
Latest reported PRAX revenue for 2024-12-31 was $8.6M. Net income was -$58.7M. Revenue was up 249.5% from 2023-12-31 to 2024-12-31. PRAX currently screens at market cap $7.38B.
APTV currently screens at market cap $14.52B and trailing P/E 40.8. PRAX currently screens at market cap $7.38B.
Not investment advice. Open the APTV and PRAX stock pages for the full models.
Not investment advice.